Signaling related to nuclear factor erythroid 2-related factor 2 (NRF2), a master regulator orchestrating antioxidant response, is enhanced in primary CLL (37) and mantle cell lymphoma (38) cells. The gene discussed is NFE2L2; the disease is B-cell chronic lymphocytic leukemia.